COAROPOLIS, Pa., May 21, 2018 /PRNewswire/ -- Stanley D. Truskie, President of the Mark D. Truskie Foundation, issued a statementthat the $2 million verdict on Wed, May 16, 2018 in favor of him and his wife, Marianne, as a result of the death of their son Mark, is a decision that will send a powerful and important message
After Mark's death on November 12, 2013, the Allegheny County coroner determined that he died from toxic levels of Celexa and Cloziral, two medications used to treat his mental condition. Mark's psychiatrist, Dr Grace Huang of the Staunton Clinic in Sewickley, PA, prescribed both medications.
"We were able to prove that Huang and the Staunton Clinic ignored two critically important FDA Safety warnings regarding Celexa, which is a medication known to cause sudden cardiac death when prescribed above certain doses," stated attorney Tyler Smith, representing the Truskie family.
"The evidence demonstrated that Huang and the Staunton Clinic prescribed Celexa to Mark at twice the allowable dose without informing Mark or the Truskies of the FDA warnings, or informing them about simple and safe tests that could have been used to protect Mark from the increased risk of harm caused by his medications," Smith added.
Truskie believes there are several valuable lessons psychiatrists and psychiatric clinics should learn from this important case including the following:
In closing, Truskie stated, "This award will help fund the Mark D. Truskie Foundation which we started in Mark's name to help protect the health and safety of those dealing with mental health problems."
Contact: Stanley D. Truskie, Ph.D. 412-979-8146 firstname.lastname@example.org www.markdtruskiefnd.org
View original content:http://www.prnewswire.com/news-releases/medical-malpractice-verdict-seen-as-powerful-message-to-mental-health-providers-300651747.html
SOURCE The Mark D Truskie Foundation
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All